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Abstract
Background: We have identified a cytosine-adenosine (CA) repeat length polymorphism in the 59-regulatory region of the
human integrin a2 gene ITGA2 that begins at 2605. Our objective was to establish the contribution of this polymorphism to
the regulation of integrin a2b1 expression, which is known to vary several-fold among normal individuals, and to investigate
the underlying mechanism(s).
Methodology/Principal Findings: In combination with the SNP C-52T, previously identified by us as a binding site for the
transcription factor Sp1, four ITGA2 haplotypes can be distinguished, in the order in which they enhance ITGA2 transcription:
(CA)12/-52C.(CA)11/-52C.(CA)11/-52T.(CA)10/-52T. By DNA affinity chromatography and chromatin immunoprecipitation
(ChIP) assays, we show that poly (ADP-ribose)polymerase-1 (PARP-1) and Ku80/70 bind specifically and with enhanced
affinity to the longer (CA)12 repeat alleles.
Conclusions/Significance: The increased binding of PARP-1 and Ku80/70, known components of transcription co-activator
complexes, to the longer (CA)12 alleles of ITGA2 coincides with enhanced a2b1 expression. The most likely explanation for
these findings is that PARP-1 and Ku80/70 contribute to the transcriptional regulation of ITGA2. These observations provide
new insight into the mechanisms(s) underlying haplotype-dependent variability in integrin a2b1 expression in human
platelets and other cells.
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Introduction
The fact that cellular integrin a2b1 levels can vary up to ten-
fold among normal, healthy subjects was first discovered on blood
platelets [1,2], where it leads to variation in adhesive function.
Among patients with a genetic basis for impaired hemostasis or an
increased propensity for thrombosis, differences in a2b1 can
further influence risk for negative outcomes [3,4,5,6]. However,
the integrin a2b1 is expressed by a large variety of cell types, and
comparable variation has now been observed in, for example,
fibroblasts and keratinocytes, where it may have an impact on
wound healing or other physiologic functions [7]. The genetic
basis for this heritable variation has been the subject of a
comprehensive study by our lab, and progress has been made in
understanding the variety of mechanisms, some species-dependent
[8], that control expression of this integrin.
We [1,2] previously identified and characterized an ITGA2
proximal promoter polymorphism at -52 (C-52T) that decreases
significantly the binding of the transcription factor Sp1, known to
be a key enhancer of ITGA2 transcription [9]. A T at position -52
disrupts what is otherwise a highly favorable Sp1 binding site and
decreases its binding by 8–10 fold [2]. This SNP, in linkage
disequilibrium with two coding region SNPs, C807T [10,11] and
G1648A [12] defines five common and several rare ITGA2
haplotypes [13].
The existence of variability in CA repeat length at this position
in the ITGA2 promoter was originally reported in abstract form by
Sydor et al. [14], but not precisely defined. In the present report,
we define the CA repeat length polymorphism as 10 to 12 repeats
with the 39 sequence beginning at 2605, we show that it is
in linkage disequilibrium with C-52T based on an analysis of
132 human chromosomes, and we analyze its contribution to
transcription vis-a `-vis C-52T in megakaryocytic (MK) and non-
megakaryocytic (non-MK) cell lines.
Results
59-Regulatory Region CA Repeat Sequence
In this study, we have identified a polymorphic CA repeat
sequence that begins at position 2605 within the 59-regulatory
region of ITGA2 (encompassing position 2878903 to 2878924
of NCBI NT_006713). Based on the sequence of 132 human
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frequency of each in a white, non-Hispanic population is:
(CA)10=0.072; (CA)11=0.567; and (CA)12=0.361. A rare
(CA)13 allele was detected only on two chromosomes. A
comparison of these 132 human haplotypes confirmed complete
linkage disequilibrium between -52C and (CA)12 and between -
52T and (CA)10 (Chi-square=80.016; p,0.001) (Table 1).
An obvious question is whether this modest variation in CA
repeat length might have an influence on ITGA2 transcription,
independently of -52C/T (nucleotide 2879425 in NT_006713).
To address this question, we cloned a 1.8 Kb segment of the
ITGA2 59-regulatory/promoter region (bp 21793 through +56)
into the LUC reporter plasmid pgl2b.
To analyze the combined effect of the CA repeat polymorphism
and C-52T, six variants of the 1.8 Kb segment were created, each
bearing 10, 11 or 12 CA repeats at the 2605 site and either T or
C at position -52. The relative activity of these constructs was
measured in three human cell lines with very different back-
grounds: HEK293, a human embryonic kidney epithelial cell line;
HeLa, a cervical cancer cell line; and Dami, a human
megakaryocytic cell line (Figure 1).
In the context of -52C (white bars), overall transcriptional
activity was increased, as expected. In HEK293, mean luciferase
activity in the presence of the (CA)12 repeat is 1.5- and 2.7-fold
higher than that obtained in the presence of the (CA)11 and (CA)10
repeat, respectively. In Dami cells, the corresponding increases,
1.8- and 5.3-fold, are more dramatic. In HeLa cells, the equivalent
increases are 1.6-fold and 8.1-fold.
In the context of -52T (black bars), overall transcriptional
activity was significantly attenuated in all cell lines (Figure 1). The
presence of the (CA)12 repeat still had an incremental effect on
luciferase activity in Dami cells, with 1.2- fold and 4.3-fold
increases relative to that observed with the (CA)11 or (CA)10
repeat, respectively. On the other hand, in either HEK293 or
HeLa cells, there was no increase in luciferase activity between the
(CA)12 repeat and the (CA)11 repeat, and only a modest increase in
activity relative to the (CA)10 repeat (1.8- and 2.2-fold,
respectively).
Taken together, these results indicate that the CA repeat
sequence of itself has little effect on transcriptional activity under
conditions where Sp1 binding would be minimized (in the
presence of -52T). On the other hand, when Sp1-driven
transcription is optimized by the presence of -52C, increasing
CA repeat length enhances that activity.
Association of CA Repeat Number with Platelet a2b1
Expression
We obtained the strongest confirmation of an effect of CA
repeat length on ITGA2 expression by measuring the level of
platelet surface a2b1( Figure 2A) in comparison to the level of
platelet aIIbb3( Figure 2B) between normal subjects with known
ITGA2 haplotypes. To simplify the analysis, donors were selected
who are homozygous for both CA repeat length and the C-52T
allele; to minimize any effect of sample manipulation, platelet
surface a2b1 content was measured in whole blood, as previously
described [10].
The data are presented as box plots to present the maximum
amount of statistical information in a visual format. Donors are
grouped into four datasets, comparing donors homozygous for
(CA)12 and -52C (n=21), for (CA)11 and -52C (n=14); for (CA)11
and -52T (n=27); and for (CA)10 and -52T (n=8). The descriptive
statistics are summarized in Table 2. First, the levels of platelet
integrin aIIbb3 were virtually identical between groups
(Figure 2B)( p .0.98). On the other hand, the level of integrin
a2b1 measured with 12F1 declined progressively with decreasing
CA repeat length and the presence of -52T (Figure 2A). The
same findings were made with 6F1 and 8C12 (Table 2). All pair-
wise comparisons for each monoclonal antibody are statistically
significant (p,0.05). These results strongly support the notion that
the CA repeat length polymorphism has an independent influence
on the rate of ITGA2 transcription.
Table 1. Association of CA repeat length alleles with -52 C or
-52T on 132 human chromosomes.
CA Repeat Length
10 11 12
-52 C 0* 17 48
T 16 51 0
*number of chromosomes positive for both alleles.
doi:10.1371/journal.pone.0008743.t001
Figure 1. Transcriptional activity of ITGA2 promoter-luciferase
reporter constructs transfected into HEK293, HeLa, or Dami
cells. A luciferase reporter assay was used to compare transcriptional
activity in the presence of -52C (white bars) or -52T (black bars) within
the ITGA2 59-regulatory region (from 21793 to +56) containing (CA)10
(10), (CA)11 (11) or (CA)12 (12) repeat sequences (abscissa). The plasmid
vector (p) lacking an insert served as a baseline (negative) control.
Relative luciferase activity is indicated on the ordinate. The mean 6 SD
of three experiments is represented.
doi:10.1371/journal.pone.0008743.g001
Figure 2. Platelet a2b1 surface expression measured by flow
cytometry in whole blood. The geometric mean fluorescence
intensity (GMFI) is plotted on the ordinate. A. Surface content of
integrin a2b1 was measured by the binding of murine monoclonal
antibody 12F1. B. Expression of integrin aIIbb3 was measured by the
binding of murine monoclonal antibody AP2. Blood was analyzed from
donors who are homozygous for the following ITGA2 haplotypes:
(CA)12/-52C (12 C) (n=21); (CA)11/-52C (11 C) (n=14); (CA)11/-52T (11 T)
(n=27); and (CA)10/-52T (10 T) (n=8). For each dataset in these box
plots, the broad horizontal bar represents the median, the box
represents the second and third quartiles, and the vertical line
represents the range. In A, all pair wise comparisons are statistically
significant (p,0.001); in B, all pair wise comparisons are not statistically
significant (p.0.95). Comparable results were obtained with murine
monoclonal antibodies 6F1 and 8C12, specific for integrin a2b1 (not
shown).
doi:10.1371/journal.pone.0008743.g002
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Sequence In Vitro
We used oligonucleotide affinity chromatography to capture
proteins that bind to the (CA)12 repeat sequence in vitro (Figure 3).
To eliminate non-specific binding, we performed the affinity
chromatography in the presence of an excess of calf thymus DNA,
as recommended by Kadonaga et al. [15]. Oligonucleotide/
protein complexes were immobilized with streptavidin-Sepharose,
and bound proteins were eluted from the oligonucleotide by
addition of SDS and heating and then separated by SDS-PAGE
(Figure 3A). The initial nuclear extract is depicted in lane 1. In
the absence of calf thymus DNA, several proteins were complexed
with biotin-CA12 (lane 2), including two prominent proteins with
MWapp of 120 kDa (arrow a) and 80 kDa (arrow b). In the
presence of calf thymus DNA, the same two proteins were still
complexed with Biotin-CA12 (lane 3). The addition of a five-fold
excess of control oligonucleotide together with Biotin-CA12 (lane
4) did not inhibit the binding of the 120 and 80 kDa proteins to
Biotin-CA12. Finally, neither of these two proteins was complexed
to the control oligonucleotide alone (lane 5).
MS/MS. The 120 and 80 kDa protein bands were individually
extracted from the gel and subjected to tandem mass spectrometry
(MS/MS). Based on electrophoretic mobility and the results of
MS/MS, the two bands were identified as PARP-1 (120kDa) and
Ku80 (80 kDa) (Figure S1).
The identities of the proteins present in purified biotin-CA12/
protein complexes were confirmed by western blot, using
antibodies specific for PARP-1, Ku80, Ku70, and Sp1
(Figure 3B). Ku70 (70 kDa), although not visible in the silver -
stained gel in Figure 3A, is known to form a heterodimer with
Ku80. Sp1, which is not present in any of the oligonucleotide/
protein complexes, is not expected to bind to these CA repeat
sequences and serves as a negative control. None of these proteins
were detected in complexes formed with biotin-CA11, biotin-
CA10 or the control oligonucleotide (Figure 3B).
Chromatin Immunoprecipitation (ChIP)
We used the ChIP assay to confirm that the co-activator protein
complex is formed at the CA repeat sequence in vivo (Figure 4).
We selected established cell lines that are homozygous for (CA)12
or (CA)11, but we have not yet identified a cell line that is
homozygous for (CA)10. The HEK293 and U937 cell lines are
both homozygous for the (CA)12 repeat, while HeLa cells are
homozygous for the (CA)11 repeat. However, the U937 cell line
serves as a negative control, because it is devoid of detectable a2b1
mRNA, even though it bears the ITGA2 (CA)12 repeat. Previous
results indicate that the U937 ITGA2 promoter region is
hypermethylated at CpG sites and transcriptionally silent [16].
By western blot assays (Figure 4A), comparable levels of PARP-1,
Ku80 and Ku70 are detected in nuclear extracts of HEK293, HeLa or
U937 cells. On the other hand, the level of integrin a2i sc o n s i s t e n t l y
higher in membrane extracts from HEK293 cells (roughly, 2-fold),
relative to that found in HeLa cells, and absent from U937.
By ChIP, Ku80 and PARP-1 are specifically bound in situ to the
(CA)12 site of HEK293 cells but associate much less strongly with
the (CA)11 site of HeLa and do not associate with the (CA)12 of
U937 (Figure 4B). In contrast, neither PARP-1 nor Ku80 bound
to the negative control sequenced derived from the 39-UTR
(Figure 4C). As shown in Figure 4D, a semi-quantitative
analysis based on three experiments indicates that there is, on
average, a four-fold increase in bound PARP-1 and a six-fold
increase in bound Ku80 at the HEK293 (CA)12 site relative to the
HeLa (CA)11 site.
Discussion
In this study, we have observed that an increase in the length of
a CA repeat polymorphism in the 59-regulatory region of ITGA2
Table 2. Surface content of platelet integrins a2b1 and
aIIbb3 measured in whole blood by flow cytometry.
12F1 6F1 8C12 AP2
CA -52 n Mean SD Mean SD Mean SD Mean SD
12 C 21 13.7* 1.3 16.4 1.9 23.1 2.5 267.5 26.3
11 C 14 11.7 1.5 13.4 2.1 16.0 2.4 270.4 26.1
11 T 27 10.2 1.4 11.2 1.3 13.7 1.6 267.2 23.3
10 T 8 7.1 0.7 8.2 0.7 9.5 0.8 269.3 26.7
*Geometric Mean Fluorescence Intensity (GMFI).
The background GMFI obtained with isotype-matched non-immune mouse IgG
has been subtracted from these values.
Integrin a2b1 specific antibodies are 12F1, 6F1 and 8C12. AP2 is specific for
integrin aIIbb3.
doi:10.1371/journal.pone.0008743.t002
Figure 3. Identification of proteins that bind to the (CA)12
oligonucleotide sequence in vitro. A. One mg of Dami nuclear
extract protein was incubated with one of four biotinylated (CA)12
oligonucleotide probes in binding buffer. Oligonucleotide/protein
complexes were adsorbed to streptavidin-agarose beads, and the
bound proteins were eluted, separated by SDS-PAGE and visualized
using silver stain. The following protein samples are depicted: (lane1)
Starting nuclear extract; (lane 2) Proteins bound to CA12 in the absence
of calf thymus DNA; (lane 3) Proteins bound to CA12 in the presence of
calf thymus DNA; (lane 4); Proteins bound to CA12 in the presence of
calf thymus DNA+ 5-fold molar excess of control oligonucleotide; and
(lane 5) Proteins bound to control oligonucleotide in the presence of
calf thymus DNA. The two prominent protein bands with MWApp of
120 kDa and 80 kDa (positions indicated by arrows a and b,
respectively, to the right of the panel) were excised and processed by
MS/MS. Peptides recovered and sequenced by MS/MS are depicted in
Figure S1. The positions held by molecular weight standards
(Amersham Biosciences, Pittsburgh, PA) are indicated to the left of
the panel. B. Dami nuclear extract proteins were incubated in vitro with
the biotin-conjugated oligonucleotide probes: CA12, CA11, CA10 or
control oligonucleotide (C). The resultant oligonucleotide/protein
complexes were pulled down with streptavidin agarose. Nuclear
proteins present in the complexes were separated by SDS-PAGE and
identified by western blotting using the specific antibodies indicated to
the left of the figure. The presence of PARP-1, Ku80 and Ku70 was
confirmed in this manner. Antibodies specific for Sp1 served as a
negative control, since the oligonucleotides used in these assays does
not contain the Sp1 binding site. To confirm comparable oligonucle-
otide loading, the same samples were electrophoresed in a 2% agarose
gel and stained with ethidium bromide (probes; negative image).
doi:10.1371/journal.pone.0008743.g003
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transcription and a corresponding increase in the levels of platelet
a2b1. This ITGA2 CA repeat polymorphism and the downstream
sequence -52C that enhances Sp1 binding are in linkage
disequilibrium.
The results of a luciferase reporter system clearly show that the
length of the CA repeat correlates with the rate of transcription in
synergy with the previously defined SNP at -52. The level of reporter
activity increases when one compares the (CA)11 repeat to the (CA)10
sequence, but activity is most significantly enhanced in the presence
of the (CA)12 repeat. Thus, four haplotypes can be distinguished, in
the order in which they enhance ITGA2 transcription: (CA)12/
-52C.(CA)11/-52C.(CA)11/-52T.(CA)10/-52T.
In vivo confirmation of this relationship was obtained with blood
platelets, in which the level of integrin a2b1 content correlates
directly with the length of the CA repeat sequence in ITGA2. The
combination of the CA repeat polymorphism and the -52 C/T
SNP can readily account for the 3–4 fold variation in a2b1
expression that we have previously reported [1,10] and confirm
here.
Important information concerning the molecular basis for this
effect was obtained by DNA affinity chromatography and
chromatin immunoprecipitation (ChIP) analyses, whereby we
show that PARP-1 and Ku80/70 bind specifically and most
strongly to the (CA)12 repeat allele. The enhanced binding of
PARP-1 and Ku80/70, known components of transcription co-
activator complexes, with this allele of ITGA2 suggests that both
proteins are involved in the increased expression of a2b1i n
platelets or other cells from donors who express the( CA)12 repeat
allele. This novel finding provides new insight into an under-
standing of haplotype-dependent variability in integrin a2b1
expression.
PARP-1 binds to double-stranded DNA nicks, becomes
activated, cleaves NAD+ into nicotinamide ADP-ribose, and
polymerizes ADP-ribose on various nuclear proteins, including
histones, certain transcription factors, such as Sp1, and itself [17].
This mechanism of poly ADP-ribosylation has been shown to
contribute to various cellular processes, including DNA repair
[18], transcriptional regulation [19,20,21], and cell cycle progres-
sion [21]. Ku80 and Ku70 form the heterodimeric DNA binding
complex Ku80/70 that associates with PARP-1 and, among other
functions, contributes to the regulation of gene transcription
[22,23,24,25,26].
This study is the first to document that the presence of a CA
repeat sequence that facilitates and/or enhances the specific
binding of the PARP-1/Ku80/70 complex. Previously defined
consensus Ku80/70 binding sites are GAGAAAGA [27,28] or
AAAAGGAAA and others [29]. These sequences are not present
anywhere within 10 Kb of the 59-regulatory region of ITGA2.
Conversely, we are unaware of any previous report that CA
repeats are a preferred binding sequence for either PARP-1 or
Ku80/70.
Our study is not the first instance of a functional association
between PARP-1 and integrin genes. Regulation of the expression
of another integrin, aLb2 (LFA-1; CD11a) by PARP-1 [30] may
be implicated in the response to cellular damage by oxygen
radicals or ischemia in neurons. Microglial migration is strongly
controlled in living brain tissue by expression of this integrin,
which is regulated by the formation of a nuclear PARP–1/NF-kB-
protein complex. In addition, b1 integrin engagement by specific
antibodies has been shown to enhance histone H3 acetylation in
the mouse lung endothelial cell genome through a mechanism that
requires PARP-1 [31].
Materials and Methods
Monoclonal Antibodies and Reagents
Murine monoclonal IgG antibody 6F1 (anti-a2b1) has been
described [32] and is a gift from Dr. B. Coller (Rockefeller
University, New York, NY). The murine hybridoma 12F1
producing IgG specific for a2b1 has been well characterized
[33] and was generously provided by Dr V. Woods (University of
California at San Diego, La Jolla, CA). The murine monoclonal
IgG antibody 8C12, also specific for a2b1, was a gift from Dr. M.
Ginsberg (University of California at San Diego, La Jolla, CA).
AP2 is a murine monoclonal IgG antibody specific for the integrin
aIIbb3 developed and characterized in our laboratory [34]. Goat
anti-human Ku80, goat anti-human PARP-1, rabbit anti-human
Sp1, normal goat IgG and normal rabbit IgG were purchased
Figure 4. Chromatin Immunoprecipitation (ChIP). A. Confirma-
tion of protein composition by Western Blot. The presence of (top row
to bottom row) PARP-1, Ku70, Ku80, and integrin a2 in HEK293 cells,
which express the ITGA2 (CA)12 allele, HeLa cells, which express the
ITGA2 (CA)11 allele, or U937 cells, which do not express ITGA2, was
confirmed by western blotting. The relative content of each protein in
these three cell lines was comparable, except for the integrin a2, which
is expressed at reduced levels in HeLa cells, and is absent in U937 cells.
B. ChIP assays were performed using HEK293 cells (top row), HeLa cells
(center row) and the control cell line U937 (bottom row). U937 bears
the ITGA2 (CA)12 allele, but does not express any detectable ITGA2
mRNA, as determined by PCR (data not shown). Chromatin was sheared
by sonication, and protein-DNA complexes were immunoprecipitated
with antibodies against the PARP-1 or Ku80. The leftmost column
represents 5% of total cross-linked chromatin before immunoprecipi-
tation (5% input). Non-immune goat IgG served as a negative control
(IgG control.). DNA retrieved after washing was amplified with primers
specific for the test sequence encompassing the ITGA2 CA repeat region
(beginning at nucleotide 2708 and ending at nucleotide 2552). Data
from one experiment representative of three independent experiments
are depicted. C. ChIP assays were performed exactly as in B, except that
primers specific for a 39-UTR negative control sequence were utilized. D.
Semi-quantitation of PARP-1 and Ku80 bound to CA repeat sequences
in vivo. The results of three ChIP assays such as that depicted in
Figure 4B were analyzed semi-quantitatively. The relative binding of
PARP-1 or Ku80 to the HEK 293 CA12 compared to HeLa CA11 sites is
plotted on the ordinate as the fold-increase in density (HEK293/HeLa) of
the photographic images corresponding to the amplified DNA
sequences. Image densities were calculated using ImageJ software.
doi:10.1371/journal.pone.0008743.g004
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megakaryocytic cell line Dami was obtained as previously
described [2], and the human cell lines HeLa and HEK293 were
obtained from ATCC (Manassas, VA).
Measurement of Platelet Integrin Expression in Whole
Blood by Flow Cytometry
Platelets were obtained from whole blood, as previously
described [35], with prior informed consent and IRB approval.
Murine monoclonal antibodies specific for the integrin a2b1
complex, 6F1, 12F1, and 8C12, were used to quantitate levels of
this receptor on platelets by flow cytometry. Monoclonal antibody
AP2 was employed to quantitate the integrin aIIbb3. Each murine
monoclonal antibody (0.5 mgi n1 0ml PBS 7.4) was added to a
100 ml aliquot of whole blood anticoagulated with sodium citrate
and let stand at ambient temperature for 60 minutes with
constant, gentle mixing. FITC-F(ab9)2 goat anti-mouse IgG (heavy
and light chains; Zymed) was then added (50 ml of a 1:500
dilution), and the mixture let stand for an additional 30 minutes at
ambient temperature with mixing. The mixtures were then diluted
1:10 with PBS 7.4 and bound fluorescence was analyzed in a
FACStar Plus (Beckman-Dickinson). Platelets were gated by
forward versus side scatter, and the geometric mean fluorescence
intensity (GMFI) of bound 12F1, 8C12, AP2, or nonimmune
murine IgG was determined. The GMFI obtained for 12F1, 6F1,
8C12 or AP2 was corrected by subtracting from each the GMFI
for nonimmune IgG.
The mean and standard deviation for GMFI values from each
dataset were calculated. A Kruskal-Wallis one way analysis of
variance (ANOVA) on ranks and a pairwise multiple comparison
procedure (Holm-Sidak method) were used to determine the
statistical significance of differences between means of each group.
Plasmid Construction
A 1.9 Kb segment of the ITGA2 59-regulatory/promoter region
corresponding to nucleotides 21793 through +56 was amplified
using genomic DNA as template and the primer pair:
Human A2.F=59-ATTAATGTGAGGCAG GAGTT-39; and
Human A2.R=59-GAGGTTTGCAGAGGA TAC-39.
Variants of this 59-regulatory/promoter region construct were
generated using the QuickChange II site-directed mutagenesis kit
from Stratagene (La Jolla, CA) according to the manufacturer’s
instructions.
The polymerase chain reaction (PCR) was catalyzed by
Platinum Taq high fidelity (Invitrogen, Carlsbad, CA). The
amplicon was cloned into TOPO TA PCR2.1 vector (Invitrogen,
Carlsbad, CA), according to the manufacturer’s directions, and
subcloned into the pGl2 basic vector (Promega, Madison, WI) at
the KpnI and XhoI restriction sites.
Cell Culture
Dami cells were grown in Iscove’s modified medium supple-
mented with 10% (v/v) horse serum and 1% (v/v) Antibiotic-
Antimycotic (Gibco-Invitrogen, Inc., Carlsbad, CA). HeLa and
HEK293 cells were grown in Dulbecco’s modified Eagle’s
Medium (DMEM) supplemented with 10% (v/v) Fetal Bovine
Serum (FBS), 2 mM L-Glutamine and 1% (v/v) Antibiotic-
Antimycotic (Gibco-Invitrogen, Inc.). In the case of HEK293 or
HeLa, 5610
4 cells in 500 ml of medium were added to each well of
a 24-well microtiter plate together with 200 ng of the pGl2
construct and 20 ng of the vector pRL-TK (Promega Corporation,
Madison, WI). Transfection was initiated using Lipofectamine
2000 (Invitrogen, Carlsbad, CA), according to manufacturer’s
instructions. For Dami cells, 5610
4 cells in 350 ml of medium were
added to one well of a 24-well plate together with 200 ng of the
pGl2 construct and 20 ng of the pRL-TK vector. Transfection was
initiated by addition of Effectene (Qiagen, Valencia CA), as
previously described [36]. Dual luciferase assays (Promega) were
performed according to the manufacturer’s instructions. Luciferase
activities were measured with the Clarity Luminescence Micro-
plate Reader (Bio-Tek Instruments, Winooski, VE), and firefly
luciferase activities were normalized to Renilla luciferase activities.
Oligonucleotide Affinity Chromatography
All procedures were performed at 4uC. Nuclear extracts (1 mg
total protein) in1 mlof 25 mMHepes, pH 7.8, containing 12.5 mM
MgCl2, 2 mM dithiothreitol, 20% (vol/vol) Nonidet P-40 and 0.1 M
KCl (Hepes buffer), as described by Kadonaga et al. [15], combined
with sonicated calf thymus DNA (100 mgi n1 0ml Hepes buffer),
incubated for 10–15 minutes, and pre-cleared by adsorption with
Streptavidin-agarose beads (Amersham, Piscataway, NJ) equilibrated
i nt h es a m eb u f f e r .T h ea g a r o s eb e a d sw e r ep e l l e t e db yc e n t r i f u g a -
tion, and the supernatants were combined with one of four double-
stranded biotinylated-oligonucleotide probes in the same buffer for
1 hour on ice. The four oligonucleotide probes synthesized for
this purpose were: the putative target sequence, Biotin-59-
TCTGT(CA)12GCT-39 (CA12), Biotin-59-TCTGT(CA)11GCTCT-
39 (CA11), Biotin-59-TCTGT(CA)10GCTCTTG-39 (CA10) and the
negative control, Biotin-59-TCTGT(CA)5GTGT(CA)5GCT-39
(Control). The oligonucleotide/protein complexes were adsorbed to
pre-blocked Streptavidin-agarose, and incubated for 30 min. The
beads were then washed three times by successive incubation for
10 min in 2 ml buffer and centrifugation. After the final wash, the
beads were pelleted, warmed to ambient temperature and resus-
pended in electrophoresis buffer containing 1% sodium dodecyl
sulfate (SDS). Bound proteins were eluted by heating the samples
for 30 min at 60uC. Eluted proteins were separated by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), as previously
described [10], and visualized using the SilverXpress staining kit
(Invitrogen, Carlsbad, CA), according to the manufacturer’s
instructions. Protein identification was confirmed by subsequent
western blot assays.
Western Blot
Proteins in polyacrylamide slab gels separated by SDS-PAGE
were transferred electrophoretically to a nitrocellulose membrane
[10]. Membranes were blocked, immersed in a solution containing
the primary antibody for 2 hours at room temperature, washed
with gentle agitation, incubated in a solution containing the
secondary antibody (diluted 1/5000) for 45 minutes at room
temperature, and washed. Bound antibody was visualized by
chemiluminescence.
Mass Spectrometry
DNA affinity chromatography was performed with oligonucle-
otide CA12. Proteins were stained with the bio-safe-Coomassie
blue staining kit (Bio-Rad, Hercules, CA), according to the
manufacturer’s instructions, and the two prominent bands with
apparent molecular weights (MWapp) of 120 and 80 kilodaltons
(kDa) were excised for identification.
Tryptic peptide mixtures were analyzed by microcapillary
reverse phase chromatography coupled to an LCQ Deca XP
MAX ion-trap mass spectrometer (ThermoFinnigan, San Jose,
CA) using dynamic exclusion with MS/MS. Mass spectrometer
was fully automated during the entire procedure using the
Xcalibur 1.4 software system (ThermoFinnigan). Peptide identi-
ITGA2 Promoter CA Repeat
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(ThermoFinnigan) based on human databases.
Chromatin Immunoprecipitation (ChIP) Assay
The details of ChIP assays are provided in the Supplemental
materials (File S1).
Supporting Information
Figure S1 Identification of proteins that bind to the (CA)12
oligonucleotide sequence in vitro by mass spectrometry. One
hundred mg of Dami nuclear extract protein were incubated with
the biotinylated (CA)12 oligonucleotide probe in binding buffer.
DNA-protein complexes were adsorbed (pulled down) with
streptavidin agarose beads, and the bound proteins were eluted,
separated by SDS-PAGE and visualized using silver stain. Two
higher MWApp protein bands (Band 1 and Band 2) were excised
and processed by MS/MS. The Peptides recovered and sequenced
by MS/MS are depicted. For each peptide sequence, the minimal
cross correlation score (XC) and charge (Z) are displayed. XC is
the confidence for identification according to the charge for the
peptide recovered. Peptides in the upper list recovered from Band
1 identify it as PARP-1. Peptides in the lower list recovered from
Band 2 and identify it as Ku80.
Found at: doi:10.1371/journal.pone.0008743.s001 (0.41 MB TIF)
File S1 Supplemental Materials
Found at: doi:10.1371/journal.pone.0008743.s002 (0.04 MB
DOC)
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